Top ▲
Target not currently curated in GtoImmuPdb
Target id: 2242
Nomenclature: tousled like kinase 1
Abbreviated Name: TLK1
Family: Tousled-like kinase (TLK) family
Gene and Protein Information ![]() |
||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 766 | 2q31.1 | TLK1 | tousled like kinase 1 | |
Mouse | - | 766 | 2 C2 | Tlk1 | tousled-like kinase 1 | |
Rat | - | 516 | 3 q21 | Tlk1 | tousled-like kinase 1 |
Previous and Unofficial Names ![]() |
PKU-BETA |
Database Links ![]() |
|
Alphafold | Q9UKI8 (Hs), Q8C0V0 (Mm) |
BRENDA | 2.7.11.1 |
ChEMBL Target | CHEMBL5388 (Hs) |
Ensembl Gene | ENSG00000198586 (Hs), ENSMUSG00000041997 (Mm), ENSRNOG00000009300 (Rn) |
Entrez Gene | 9874 (Hs), 228012 (Mm), 311118 (Rn) |
Human Protein Atlas | ENSG00000198586 (Hs) |
KEGG Enzyme | 2.7.11.1 |
KEGG Gene | hsa:9874 (Hs), mmu:228012 (Mm), rno:311118 (Rn) |
OMIM | 608438 (Hs) |
Pharos | Q9UKI8 (Hs) |
RefSeq Nucleotide | NM_012290 (Hs), NM_172664 (Mm), NM_001107734 (Rn) |
RefSeq Protein | NP_036422 (Hs), NP_766252 (Mm), NP_001101204 (Rn) |
UniProtKB | Q9UKI8 (Hs), Q8C0V0 (Mm) |
Wikipedia | TLK1 (Hs) |
Enzyme Reaction ![]() |
||||
|
DiscoveRx KINOMEscan® screen ![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform. http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan Reference: 1-2 |
![]() ![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Target used in screen: TLK1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displaying the top 10 most potent ligands View all ligands in screen » |
1. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]
2. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]
Tousled-like kinase (TLK) family: tousled like kinase 1. Last modified on 29/01/2016. Accessed on 24/03/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2242.